1 Min Read
March 21 (Reuters) - Helix Biopharma Corp:
* HELIX BIOPHARMA CORP. SIGNS COLLABORATION AGREEMENT WITH PROMAB BIOTECHNOLOGIES TO CO-DEVELOP CAR-T FOR HEMATOLOGICAL MALIGNANCIES Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.